Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

SHE:300255 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 7, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	58,581	18,372	11,957	5,036	7,472	5,693
Market Cap Growth	206.30%	53.65%	137.41%	-32.59%	31.26%	11.92%
Enterprise Value	60,882	20,352	14,091	6,817	8,617	6,631
Last Close Price	63.74	19.99	13.01	5.47	8.09	6.15
PE Ratio	-	-	-	287.58	31.99	22.52
Forward PE	-	12.44	12.44	12.44	12.44	12.44
PS Ratio	63.13	17.82	8.48	2.16	2.52	2.41
PB Ratio	39.62	11.96	6.64	1.65	2.43	2.00
P/TBV Ratio	48.30	14.65	8.02	1.80	2.68	2.20
P/OCF Ratio	1214.81	326.80	354.53	1611.41	2602.11	-
EV/Sales Ratio	65.60	19.74	9.99	2.92	2.90	2.81
EV/EBITDA Ratio	-	-	-	41.33	22.68	15.64
EV/EBIT Ratio	-	-	-	63.13	26.59	17.98
EV/FCF Ratio	-418.44	-	-	-	-	-
Debt / Equity Ratio	1.75	1.66	1.32	0.82	0.57	0.47
Debt / EBITDA Ratio	-	-	-	15.10	4.58	3.14
Asset Turnover	0.20	0.23	0.27	0.42	0.61	0.56
Inventory Turnover	0.62	0.62	0.85	0.56	0.60	0.45
Quick Ratio	0.24	0.25	0.29	0.72	0.52	0.67
Current Ratio	0.87	0.91	1.19	2.18	1.97	2.12
Return on Equity (ROE)	-18.04%	-15.83%	-51.43%	0.33%	7.81%	9.01%
Return on Assets (ROA)	-2.57%	-2.45%	-13.46%	1.20%	4.15%	5.41%
Return on Capital (ROIC)	-2.94%	-2.71%	-14.74%	1.30%	4.50%	5.94%
Return on Capital Employed (ROCE)	-8.50%	-7.70%	-42.80%	2.50%	9.40%	11.70%
Earnings Yield	-0.51%	-1.36%	-10.37%	0.35%	3.13%	4.44%
FCF Yield	-0.25%	-1.00%	-1.72%	-8.50%	-4.08%	-6.73%
Dividend Yield	-	-	-	0.09%	0.32%	-
Payout Ratio	-	-	-	708.02%	26.50%	27.08%
Buyback Yield / Dilution	-35.95%	-0.58%	-4.91%	6.27%	0.23%	0.24%
Total Shareholder Return	-35.95%	-0.58%	-4.91%	6.37%	0.55%	0.24%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.